Since AMPK inhibition, either by AMPK silencing or AMPK inhibitors (e.g., compound C), contributes to hypertension [51,52], treatment modalities for AMPK activation have become more attractive reprogramming strategies. Here, PRKAA2 is linked to Hypertension.